Evidence method
Level · gp.fundamentals.capex_revenue_ratio
84.51% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CRNX · Mar 31, 2020
Crinetics Pharmaceuticals, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001564590-20-023265General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-17225.35% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
-80.65% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-25045.07% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
19523.94% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
3023.94% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History14 statesSelf-history eligible
Sep 30, 20190/6 normalizedLevel 3Dec 31, 20190/6 normalizedLevel 3Mar 31, 20200/6 normalizedLevel 3Dec 31, 20200/6 normalizedLevel 3Mar 31, 20235/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/6 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Mar 31, 20256/6 normalizedLevel 3Jun 30, 20256/6 normalizedLevel 3Dec 31, 20256/8 normalizedLevel 3Mar 31, 20266/8 normalizedLevel 3Jun 30, 20266/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 41.24%
- Current
- 84.51%
- Delta
- 43.27%
- Previous
- -3887.76%
- Current
- -17225.35%
- Delta
- -13337.59%
- Previous
- -50.86%
- Current
- -80.65%
- Delta
- -29.79%
- Previous
- -4512.32%
- Current
- -25045.07%
- Delta
- -20532.75%
- Previous
- 3479.13%
- Current
- 19523.94%
- Delta
- 16044.82%
- Previous
- 527.58%
- Current
- 3023.94%
- Delta
- 2496.37%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CRNX Fundamental State →Transitioned To · CRNX CAPEX_INTENSITY_INCREASED →Transitioned To · CRNX CASH_GENERATION_DECREASED →Transitioned To · CRNX GROWTH_DECREASED →Transitioned To · CRNX PROFITABILITY_DECREASED →Transitioned To · CRNX R_AND_D_INTENSITY_INCREASED →Transitioned To · CRNX SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.